<?xml version="1.0" encoding="UTF-8"?>
<p>Patients should be evaluated after 8 weeks, and in cases of favorable clinical response, they should maintain the drug for another 6 months. In the event of failure to respond to HCQ, MTX should be prescribed. For cases of MTX failure, the physician should refer the patient to a rheumatologist. </p>
